Le notizie dalla Borsa Italiana del adc-therapeutics-announces-updates-on-lotis-7-clinical-trial-evaluating-zynlonta-in-combination-with-glofitamab-or-mosunetuzumab-in-patients-with-relapsed-refractory-b-cell-non-hodgkin-lymphoma-2075420


Condividi